News
Viglya wishes to establish transparent and open communication with its stakeholders. This section offers new and updated information regarding the company and the life science sector.
(Cas) AEMPS: Cese de comercialización, retirada del mercado y recuperación de las ampollas antiedad Vichy Liftactiv Specialist Peptide-C
Sorry, this entry is only available in European Spanish. For the sake of viewer convenience, the content is shown below in the alternative language. You may click the link to switch the active language.La empresa [...]
EMA: Hydroxyethyl-starch solutions for infusion recommended for suspension from the market
Update as of 25 May 2022: On 24 May 2022, the European Commission issued a legal decision confirming the suspension of the marketing authorisations of HES solutions for infusion. If necessary for public health reasons, individual EU Member States [...]
EMA: European Immunization Week 2022: Statement by Executive Director Emer Cooke – Why vaccines contribute to a “Long Life for All”
The European Immunization Week, which takes place every year between 24 and 30 April, is a great opportunity to remind ourselves how lucky we are to be living in a world where vaccines exist. We [...]
FDA Warns of Risks Associated with Non-Invasive Prenatal Screening Tests
Today, the U.S. Food and Drug Administration is warning the public of the risk of false results, inappropriate use and inappropriate interpretation of results with non-invasive prenatal screening (NIPS) tests, also called cell-free DNA tests [...]
EMA: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 4-7 April 2022
mRNA COVID-19 vaccines: PRAC finds no link with autoimmune hepatitis The PRAC has concluded that available evidence does not support a causal link between COVID-19 vaccines Comirnaty and Spikevax and very rare cases of autoimmune hepatitis (AIH). AIH is [...]
TGA: Ferngrove Pharmaceuticals Pty Ltd fined $13,320 for alleged breaches of therapeutic goods legislation
The Therapeutic Goods Administration (TGA), part of the Department of Health, has issued an infringement notice of $13,320 to Sydney-based company Ferngrove Pharmaceuticals Pty Ltd (Ferngrove) for alleged contraventions of the Therapeutic Goods Act 1989 in relation [...]